These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38554062)

  • 1. Novel B-cell subsets as potential biomarkers in idiopathic inflammatory myopathies: insights into disease pathogenesis and disease activity.
    Reyes-Huerta RF; Mandujano-López V; Velásquez-Ortiz MG; Alcalá-Carmona B; Ostos-Prado MJ; Reyna-Juárez Y; Meza-Sánchez DE; Juárez-Vega G; Mejía-Domínguez NR; Torres-Ruiz J; Gómez-Martín D; Maravillas-Montero JL
    J Leukoc Biol; 2024 Jun; 116(1):84-94. PubMed ID: 38554062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies.
    Wilkinson MGL; Radziszewska A; Wincup C; Ioannou Y; Isenberg DA; Manson JJ; Jury EC
    Rheumatology (Oxford); 2020 Jan; 59(1):194-204. PubMed ID: 31292651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A local antigen-driven humoral response is present in the inflammatory myopathies.
    Bradshaw EM; Orihuela A; McArdel SL; Salajegheh M; Amato AA; Hafler DA; Greenberg SA; O'Connor KC
    J Immunol; 2007 Jan; 178(1):547-56. PubMed ID: 17182595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort.
    Hou Y; Liu M; Luo YB; Sun Y; Shao K; Dai T; Li W; Zhao Y; Yan C
    Neuromuscul Disord; 2019 Jan; 29(1):5-13. PubMed ID: 30579751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of peripheral blood B cell subsets in Chinese patients with adult idiopathic inflammatory myopathies.
    Wang Y; Zhu L; Ju B; Luo J; Li Q; Lv X; Pu D; Hao Z; Wang J; He L
    Clin Exp Rheumatol; 2022 Feb; 40(2):260-266. PubMed ID: 34905483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in idiopathic inflammatory myopathies.
    Salomonsson S; Lundberg IE
    Autoimmunity; 2006 May; 39(3):177-90. PubMed ID: 16769651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral Blood Lymphocyte Subsets and Heterogeneity of B Cell Subsets in Patients of Idiopathic Inflammatory Myositis with Different Myositis-specific Autoantibodies.
    Pan Z; Li M; Zhang P; Li T; Liu R; Liu J; Liu S; Zhang Y
    Inflammation; 2024 May; ():. PubMed ID: 38755405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal Muscle Involvement in Antisynthetase Syndrome.
    Noguchi E; Uruha A; Suzuki S; Hamanaka K; Ohnuki Y; Tsugawa J; Watanabe Y; Nakahara J; Shiina T; Suzuki N; Nishino I
    JAMA Neurol; 2017 Aug; 74(8):992-999. PubMed ID: 28586844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Shah M; Mamyrova G; Huber AM; Rice MM; Targoff IN; Miller FW;
    Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients.
    Sosa-Hernández VA; Torres-Ruíz J; Cervantes-Díaz R; Romero-Ramírez S; Páez-Franco JC; Meza-Sánchez DE; Juárez-Vega G; Pérez-Fragoso A; Ortiz-Navarrete V; Ponce-de-León A; Llorente L; Berrón-Ruiz L; Mejía-Domínguez NR; Gómez-Martín D; Maravillas-Montero JL
    Front Immunol; 2020; 11():611004. PubMed ID: 33343585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Changes in Peripheral Lymphocyte Subpopulations in Adult Onset Type 1 Diabetes.
    Teniente-Serra A; Pizarro E; Quirant-Sánchez B; Fernández MA; Vives-Pi M; Martinez-Caceres EM
    Front Immunol; 2021; 12():784110. PubMed ID: 34938295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic inflammatory myopathies.
    Dimachkie MM
    J Neuroimmunol; 2011 Feb; 231(1-2):32-42. PubMed ID: 21093064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jo-1 autoantigen-specific B cells are skewed towards distinct functional B cell subsets in anti-synthetase syndrome patients.
    Young-Glazer J; Cisneros A; Wilfong EM; Smith SA; Crofford LJ; Bonami RH
    Arthritis Res Ther; 2021 Jan; 23(1):33. PubMed ID: 33468230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.
    Pagnini I; Vitale A; Selmi C; Cimaz R; Cantarini L
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):34-44. PubMed ID: 26429707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Transplant Patients Show a Dissimilar Peripheral B-Cell Subset Ratio Compared With Healthy Controls.
    Schreurs I; Meek B; Hijdra D; Rodriguez Gomez M; van Moorsel CHM; Luijk HD; Kwakkel-van Erp JM; Oudijk EJ; van Kessel DA; Grutters JC
    Exp Clin Transplant; 2020 Apr; 18(2):234-241. PubMed ID: 32279657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies.
    Ruck T; Bittner S; Afzali AM; Göbel K; Glumm S; Kraft P; Sommer C; Kleinschnitz C; Preuße C; Stenzel W; Wiendl H; Meuth SG
    Oncotarget; 2015 Dec; 6(41):43230-43. PubMed ID: 26646698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies.
    O'Hanlon TP; Carrick DM; Targoff IN; Arnett FC; Reveille JD; Carrington M; Gao X; Oddis CV; Morel PA; Malley JD; Malley K; Shamim EA; Rider LG; Chanock SJ; Foster CB; Bunch T; Blackshear PJ; Plotz PH; Love LA; Miller FW
    Medicine (Baltimore); 2006 Mar; 85(2):111-127. PubMed ID: 16609350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Semin Neurol; 2012 Jul; 32(3):227-36. PubMed ID: 23117947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets.
    Espinosa-Ortega F; Gómez-Martin D; Santana-De Anda K; Romo-Tena J; Villaseñor-Ovies P; Alcocer-Varela J
    Clin Exp Immunol; 2015 Mar; 179(3):520-8. PubMed ID: 25348796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.